This is from Chat GPT when I asked to compare Thailand to Western Europe as far as traveling with research peptides:
So, like many things in the grey community, the answer depends on the context. Trips to Disney or Spain, probably not so risky with grey peptides, Thailand more risky.
Thailand presents a materially greater risk than Western Europe. I would not take typical gray-market peptide vials—vendor-labeled, “research use only,” or unlabeled—into Thailand.
Thailand’s traveler exception is written for an actual patient carrying an actual medication: no more than a 30-day supply , in its original properly labeled container , accompanied by a physician’s prescription. (
FDA Thailand) A gray-market vial does not fit that description cleanly, even when the peptide itself is not classified as a narcotic or psychotropic substance.
The particular pitfalls in Thailand[archived internal link]
A vial marked only “RETA 20 mg,” “CAG 10 mg,” or “research use only” is difficult to characterize as prescribed personal medication.
An unlabeled vial or prefilled syringe is worse because you cannot reliably prove its contents.
Multiple peptides, numerous vials, BAC water and syringes together can look more like an importation kit than ordinary vacation medication.
Thailand limits ordinary personal medication to 30 days . For a longer trip, carrying 60 days of gray-market product would be especially difficult to justify under that exception. (
FDA Thailand)
Thai Customs treats certain health products as restricted goods requiring authorization from the relevant agency. (
Customs Thailand)
Most weight-loss peptides are not narcotics merely because they are peptides. The likely issue would be unauthorized or unidentified medicine , possible seizure, questioning, or refusal to allow entry—not automatically a narcotics prosecution. But Thailand is not where I would volunteer for that argument.
Western Europe[archived internal link]
Western Europe is somewhat more forgiving for recognizable personal medication , but gray market remains a gray area rather than a safe harbor.
France permits quantities compatible with personal therapeutic use and may require the original valid prescription; without a prescription, its general guidance refers to limited personal-treatment quantities. (
Douane Gouv) Spain states that travelers may carry personal medication but can be required to present a prescription or medical report on entry or exit. (
AEMPS) Italy’s border-health authorities specifically oversee pharmaceuticals not authorized in Italy that arrive from outside the EU. (
Salute)
Once inside the Schengen area, there usually is not a customs inspection every time you take a train from France to Spain or Italy. Your most important exposure is generally the first external border where you enter Europe , although inspections can still occur later. The UK is separate from both the EU and Schengen; its controlled-medication traveler policy specifically requires medicines to have been lawfully prescribed and dispensed. (
GOV.UK)
My practical recommendation: use only a prescribed, pharmacy-dispensed product for Thailand. Keep it in the original packaging, carry a doctor’s letter listing the full generic name, strength, dosage, indication and amount, and stay within 30 days. For a gray-market investigational peptide such as retatrutide, cagrilintide or eloralintide, I would leave it home rather than risk Thai customs. Western Europe is less concerning in practice, but I would still avoid unlabeled or “research” vials—particularly when first entering through Italy.
Just kidding!
